ES2296987T3 - Procedimiento para la deteccion de estres oxidativo y kit para su implementacion. - Google Patents

Procedimiento para la deteccion de estres oxidativo y kit para su implementacion. Download PDF

Info

Publication number
ES2296987T3
ES2296987T3 ES02762445T ES02762445T ES2296987T3 ES 2296987 T3 ES2296987 T3 ES 2296987T3 ES 02762445 T ES02762445 T ES 02762445T ES 02762445 T ES02762445 T ES 02762445T ES 2296987 T3 ES2296987 T3 ES 2296987T3
Authority
ES
Spain
Prior art keywords
baselineskip
dddseqskip
hskip
hfill
oxidative stress
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02762445T
Other languages
English (en)
Spanish (es)
Inventor
Joel Pincemail
Jacques Piette
Daniel Marechal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Probiox SA
Original Assignee
Probiox SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiox SA filed Critical Probiox SA
Application granted granted Critical
Publication of ES2296987T3 publication Critical patent/ES2296987T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analyzing Materials Using Thermal Means (AREA)
ES02762445T 2001-08-14 2002-08-13 Procedimiento para la deteccion de estres oxidativo y kit para su implementacion. Expired - Lifetime ES2296987T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE2001/0545 2001-08-14
BE2001/0545A BE1014949A3 (fr) 2001-08-14 2001-08-14 Procede de detection de stress oxydant et trousse pour sa mise en oeuvre.

Publications (1)

Publication Number Publication Date
ES2296987T3 true ES2296987T3 (es) 2008-05-01

Family

ID=3897081

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02762445T Expired - Lifetime ES2296987T3 (es) 2001-08-14 2002-08-13 Procedimiento para la deteccion de estres oxidativo y kit para su implementacion.

Country Status (7)

Country Link
US (1) US7288374B2 (de)
EP (1) EP1423518B1 (de)
AT (1) ATE378404T1 (de)
BE (1) BE1014949A3 (de)
DE (1) DE60223561T2 (de)
ES (1) ES2296987T3 (de)
WO (1) WO2003016527A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0225885D0 (en) * 2002-11-06 2002-12-11 Isis Innovation Quantifying exposure to stress
US20040265926A1 (en) * 2002-11-21 2004-12-30 Leong Ng Bodily fluid markers of tissue hypoxia
WO2005020984A2 (en) * 2003-08-29 2005-03-10 Aaipharma Inc. Method of reducing the risk of oxidative stress
GB0409153D0 (en) * 2004-04-23 2004-05-26 Randox Lab Ltd Method of diagnosis
ES2315034B1 (es) * 2004-07-02 2009-12-30 Laboratorios Indas, S.A. Proteina de choque termico 27 (hsp-27) como marcador de enfermedad cardiovascular.
WO2006118988A2 (en) * 2005-04-29 2006-11-09 University Of Tennessee Research Foundation Cellular biomarker antioxidant assay and uses thereof
FR2894030B1 (fr) * 2005-11-30 2008-07-04 Michel Brack Procede de determination d'un score representatif du stress oxydatif d'un patient, sur une echelle de 0 a 10
US7998698B2 (en) * 2006-05-31 2011-08-16 Health Research Inc. Method for predicting susceptibility to radiation pneumonitis
US7550299B2 (en) * 2006-08-03 2009-06-23 The United States Of America As Represented By The Department Of Veterans Affairs Method for predicting onset/risk of atrial fibrillation (AF)
FR2923609A1 (fr) 2007-11-13 2009-05-15 Thierry Patrice Test pour la mesure de la resistance au stress oxydant et ses applications
EP2219659A4 (de) * 2007-11-19 2010-11-17 Bionovo Inc Verfahren zum nachweis und zur behandlung von krebs mit einem extrakt aus scuttelaria barbata
WO2012094580A2 (en) * 2011-01-07 2012-07-12 High Point Pharmaceuticals, Llc Compounds that modulate oxidative stress
WO2012162260A2 (en) 2011-05-21 2012-11-29 Kdt, Llc. Transgenic biosensors
WO2013035071A1 (en) 2011-09-08 2013-03-14 Yeda Research And Development Co. Ltd. Novel risk biomarkers for lung cancer
RU2534821C2 (ru) * 2012-05-18 2014-12-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" Способ диагностики окислительного стресса измерением экспрессии кислородчувствительных генов (варианты)
CA2895089C (en) 2012-12-14 2019-02-26 The Procter & Gamble Company Fragrance materials
WO2014100361A1 (en) * 2012-12-19 2014-06-26 The Johns Hopkins University Protection from oxidative damage by gene transfer by glutamate cysteine ligase and glutathione synthase
WO2014144265A1 (en) * 2013-03-15 2014-09-18 The Procter & Gamble Company A noninvasive method for measuring oxidative stress and oxidative damage from skin
RU2540500C2 (ru) * 2013-05-07 2015-02-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт кардиологии" Сибирского отделения Российской академии медицинских наук Способ прогнозирования ранней стадии апоптоза
RU2545900C2 (ru) * 2013-05-07 2015-04-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт кардиологии" Сибирского отделения Российской академии медицинских наук Способ диагностики апоптоза лимфоцитов
US9995758B1 (en) * 2014-10-31 2018-06-12 Western Autotroph Company LLC Methods and systems for controlling oxidative stress in humans and animals
WO2016077467A1 (en) 2014-11-11 2016-05-19 The Johns Hopkins University Biomarkers useful in the treatment of subjects having diseases of the eye
US10434141B2 (en) 2016-05-31 2019-10-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
EP3684756A4 (de) 2017-09-20 2020-10-28 NaCuity Pharmaceuticals, Inc. Verfahren zur herstellung von n-acetylcysteinamid und derivaten davon
US11548851B2 (en) 2017-09-20 2023-01-10 Nacuity Pharmaceuticals, Inc. Method for preparation of n-acetyl cysteine amide and derivatives thereof
US11091433B2 (en) 2017-09-20 2021-08-17 Nacuity Pharmaceutials, Inc. Method for preparation of N-acetyl cysteine amide and derivatives thereof
US20190135741A1 (en) 2017-11-09 2019-05-09 Nacuity Pharmaceuticals, Inc. Methods of Making Deuterium-Enriched N-acetylcysteine Amide (D-NACA) and (2R, 2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress
CN109797133A (zh) * 2019-01-09 2019-05-24 珠海金肽生物科技有限公司 多潜能细胞培养组合物及制备方法和应用
EP3908341A4 (de) 2019-01-11 2022-03-02 NaCuity Pharmaceuticals, Inc. Behandlung von altersbedingter makuladegeneration, glaukom und diabetischer retinopathie mit n-acetylicysteinamid (naca) oder 2r,2r')-3-3'-disulfandiyl bis (2-acetamidopropanamid) (dinaca )
CN112684020B (zh) * 2020-12-01 2023-12-29 哈尔滨医科大学 一种用于评价个体锌营养状态的生物标志物及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2534631B2 (ja) * 1986-01-17 1996-09-18 プリベンティブ メディシン インスティテュート Ｄｎａが関連する病気にかかり易い体質または該病気に対する感受性を測定するための試験
CA2271068A1 (en) * 1996-11-12 1998-05-22 Zehava Grosman Method for identifying translationally regulated genes
JP2002504812A (ja) * 1997-05-21 2002-02-12 クローンテック ラボラトリーズ，インコーポレイテッド 核酸アレイ
JP2002514441A (ja) * 1998-05-11 2002-05-21 クアーク バイオテク インコーポレイテッド 遺伝子の同定方法
ATE350486T1 (de) * 1998-05-15 2007-01-15 Quark Biotech Inc Durch mechanischen stress induzierte gene, deren expressionsprodukte und deren verwendung.
US6569683B1 (en) * 1998-05-29 2003-05-27 Nikken Foods Co., Ltd. Use of oxidative stress diagnostic plot as a health indicator for assessing oxidative stress and its control in humans
WO2000009750A1 (en) * 1998-08-14 2000-02-24 The Trustees Of The University Of Pennsylvania Compositons, kits, and methods for hydrodynamic stress-related regulation of gene expression
WO2000065095A2 (en) * 1999-04-23 2000-11-02 Clontech Laboratories, Inc. Methods and compositions for performing array based hybridization assays
US6607885B1 (en) * 1999-10-15 2003-08-19 E. I. Du Pont De Nemours And Company Method for high-density microarray medicated gene expression profiling
WO2001032802A1 (en) * 1999-10-29 2001-05-10 The Cleveland Clinic Foundation Method and apparatus for predicting male infertility
WO2001046468A2 (en) * 1999-12-21 2001-06-28 Eirx Therapeutics Ltd Screening method for ros-induced apoptosis in a cell
US6541265B2 (en) * 2001-05-09 2003-04-01 University Of Florida Method and system to test a substance for inflammatory or oxidant properties
US7153272B2 (en) * 2002-01-29 2006-12-26 Nanotherapeutics, Inc. Methods of collecting and analyzing human breath

Also Published As

Publication number Publication date
DE60223561T2 (de) 2008-05-29
WO2003016527A2 (en) 2003-02-27
WO2003016527A3 (en) 2003-12-31
BE1014949A3 (fr) 2004-07-06
US20050112572A1 (en) 2005-05-26
EP1423518A2 (de) 2004-06-02
US7288374B2 (en) 2007-10-30
DE60223561D1 (de) 2007-12-27
EP1423518B1 (de) 2007-11-14
ATE378404T1 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
ES2296987T3 (es) Procedimiento para la deteccion de estres oxidativo y kit para su implementacion.
Jacob et al. Markers of oxidant stress that are clinically relevant in aging and age-related disease
Leblond et al. Downregulation of intestinal cytochrome p450 in chronic renal failure
Naito et al. Oxidative stress involvement and gene expression in indomethacin-induced gastropathy
CN110791560B (zh) 一种用于阿尔茨海默病诊断和/或治疗的miRNA标志物
JP2004530416A5 (de)
Chen et al. Maternal protein restriction affects gene expression profiles in the kidney at weaning with implications for the regulation of renal function and lifespan
WO2013040419A1 (en) Compositions and methods for treating hyperprolinemia-associated mental disorders
JP2009545524A5 (de)
Duraisamy et al. Epigenetic modifications in peripheral blood as potential noninvasive biomarker of diabetic retinopathy
WO2014136870A1 (ja) Ｒｎａ修飾の簡易検出法、及び該検出法を用いた２型糖尿病の検査方法
Wild et al. RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid–induced protoporphyrin IX in vitro
Chalchat et al. Circulating microRNAs after a 24‐h ultramarathon run in relation to muscle damage markers in elite athletes
Masi et al. Increased levels of 5′, 8-Cyclopurine DNA lesions in inflammatory bowel diseases
CN110229899B (zh) 用于结直肠癌早期诊断或预后预测的血浆标记物组合
Yoon et al. Smoking status-dependent association of the 27-bp repeat polymorphism in intron 4 of endothelial nitric oxide synthase gene with plasma nitric oxide concentrations
CN108267584B (zh) 一种检测斑马鱼体内胰脂肪酶活性的方法与应用
Li et al. Differentially Expressed Functional LncRNAs in human subjects with metabolic syndrome reflect a competing endogenous RNA network in circulating extracellular vesicles
Chambers et al. Tau mRNA isoforms following sciatic nerve axotomy with and without regeneration
US20140378388A1 (en) Treatment of uterine leiomyomata
Reszka et al. Level of selenoprotein transcripts in peripheral leukocytes of patients with bladder cancer and healthy individuals
JP2012019784A (ja) 疲労の判定方法
Elsaid et al. Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients
Veljković et al. Local and systemic oxidative stress in Balkan endemic nephropathy is not associated with xanthine oxidase activity
KR102497196B1 (ko) 전립선암 진단 점수 계산 방법 및 그 용도